AKT1 and cancer: In previous reports, Akt activation was found to increase the activity of A Disintegrin and Metalloproteinase 17 (ADAM17), which increases the shedding of heparin-binding EGF (HB-EGF) and amphiregulin (AREG) from the cancer cell surface, leading to EGFR activation65,66.